Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-002446-21 | EudraCT Number | ||
| 2024-514545-11-00 | EU Trial (CTIS) Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Instituto de Investigación Biomédica de Salamanca | OTHER |
| Spanish Clinical Research Network - SCReN | NETWORK |
| Institut d'Investigacions Biomèdiques August Pi i Sunyer | OTHER |
Not provided
Not provided
Not provided
Phase III, multicenter, randomized, open-label, multicenter clinical trial comparing treatment with allogeneic mesenchymal cells versus autologous mesenchymal cells and versus active control with hyaluronic acid in patients with knee osteoarthritis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Autologous Mesenchymal Stromal Cells (MSC) | Experimental | Treatment with 40 millions of autologous autologous adult mesenchymal stem cells from expanded bone marrow administered intra-articularly. |
|
| Allogenic Mesenchymal Stromal Cells (MSC) | Experimental | Treatment with 40 millions of adult allogeneic expanded bone marrow mesenchymal stem cells administered intra-articularly. |
|
| Active Control | Active Comparator | Hyaluronic Acid 60mg/3ml administered intra-articularly. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Autologous MSCs | Drug | Intra-articular injection 40 million/4 ml. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Range of motion. | Evaluation of clinical-functional response using Joint range-of-motion evaluation (Flexion score 0º-140º / Extension score -140º-0º / Hyperextension: positive degrees from 0). | 12 months |
| Pain self-assessment. | Evaluation of pain using Visual Analogue Scale (VAS) (Pain self-assessment score range from 0 -no pain- to 10 -maximum-). | 12 months |
| Knee Osteoarthritis. | Evaluation of Knee Osteoarthritis using Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) [measures five items for pain (score range from 0 -no pain- to 20 -maximum-), two for stiffness (score range from 0-no stiffness- to 8 -maximum-), and 17 for functional limitation (score range from 0 -no limitation- to 68 -maximum-)] | 12 months |
| Functional response. | Evaluation of functional response using Lequesne Algofunctional Index (score range from 0 to 24). It includes measures of pain (5 questions), walking distance (1 question) and activities of daily living (4 questions) with separate versions for the hip and knee. The scores for each question are summed to obtain a combined score of disease severity. Scores 1 to 4 are classified as mild osteoarthrosis; 5 to 7, moderate; 8 to 10, severe; 11 to 13, very severe; and 14 and above, extremely severe. | 12 months |
| X-ray changes of osteoarthritis. | Radiological response using Kellgren and Lawrence classification system (grade from 0 to 4):
|
| Measure | Description | Time Frame |
|---|---|---|
| Perceived general well-being. | Evaluation of quality of life using Short Form-12 Health Survey questionnaire (SF12) [score range from 0 (the worst health status for that dimension) to 100 (the best health status)] | 6, 12 and 24 months |
| Feasibility assessment of a multicentre strategy production of both cell types with several Cell Production Units |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Fermín Sánchez-Guijo | IBSAL - University Hospital of Salamanca | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Clinic | Barcelona | Spain | ||||
| Hospital Clínico Universitario San Carlos |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Hospital Universitari de Bellvitge |
| OTHER |
Randomized, Open-label, Clinical Trial comparing 3 active treatments.
Not provided
Not provided
Not provided
Not provided
| Allogenic MSCs | Drug | Intra-articular injection 40 million/4 ml. |
|
| Hyaluronic Acid | Drug | Intra-articular injection 60mg / 3 ml . |
|
|
| 12 months |
| Radiological response using nuclear magnetic resonance imaging. | Evaluation of radiological response using T2 mapping nuclear magnetic resonance imaging (screening visit global mean of T2 values versus 12 months visit global mean of T2 values). | 12 months |
Rate of products not conforming to the validation criteria in each arm of experimental treatment. |
| 24 months |
| Evaluation of presence of adverse events related with investigational medical product (IMP). | Rate of adverse events and other pharmacovigilance parameters in the three treatment arms. | 24 months |
| Evaluation of products obtained by genomic study and potency studies of the final products of all cell types (exploratory objective) | Studies of the cell product. In this exploratory objective, genomic studies will be carried out using RNA-seq and open array on the advanced therapy drugs manufactured in the study (both autologous and allogeneic), and a correlation will be made with clinical and biological parameters and with the response. | 30 days |
| Evaluate induced changes in circulating cells of the immune system after cell treatment (exploratory objetive) | Evaluation of cell populations (NK cells, B cells, regulatory T cells, myeloid suppressor cells, T cell populations) by flow cytometry, prior to administration of cell therapy, at 7 days and 30 days. Evaluation of activation and inhibition markers in T lymphocytes (CD69, HLADR, CD137, PD1, LAG3 and TIM3) prior to administration of cell therapy, at 7 days and 30 days Population of inflammatory cytokines circulating in peripheral blood (Plex deB iorad -reference M50DKFADY), prior to administration of treatment, at 7 days and 30 days | 30 days |
| Madrid |
| Spain |
| Hospital Fundación Jiménez Díaz | Madrid | Spain |
| Hospital Gregorio Marañón | Madrid | Spain |
| Hospital Universitario Virgen de la Victoria | Málaga | Spain |
| Hospital Universitario Virgen de la Arrixaca | Murcia | Spain |
| Clínica Universidad de Navarra | Pamplona | Spain |
| Complejo Asistencial Universitario de Salamanca | Salamanca | 37007 | Spain |
| ID | Term |
|---|---|
| D020370 | Osteoarthritis, Knee |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006820 | Hyaluronic Acid |
| ID | Term |
|---|---|
| D006025 | Glycosaminoglycans |
| D011134 | Polysaccharides |
| D002241 | Carbohydrates |
Not provided
Not provided